Paradigm Asset Management
EW icon

Paradigm Asset Management’s Edwards Lifesciences EW Stock Holding History

Paradigm Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$155K Hold
1,800
– – 0.04% 252
2026
Q2 		$163K Buy
+1,800
New +$151K 0.03% 273
2022
Q4 		– Sell
-3,100
Closed -$256K – 528
2022
Q3 		$256K Sell
3,100
-500
-14% -$48.1K 0.09% 260
2022
Q2 		$342K Buy
+3,600
New +$373K 0.1% 253

Other funds holding EW

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Paradigm Asset Management's EW Position: Q3 2026 in Review

Paradigm Asset Management held its Edwards Lifesciences (EW) position steady in Q3 2026 at 1,800 shares worth $155K. The position accounts for 0.04% of the portfolio, ranked #252.

Paradigm Asset Management first reported a position in EW in Q2 2022 and has held it in 4 quarters since. The position peaked at $342K in Q2 2022. 966 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Paradigm Asset Management held 1,800 shares of Edwards Lifesciences worth $155K as of Q3 2026.
  • Paradigm Asset Management left its Edwards Lifesciences share count unchanged in Q3 2026.
  • Edwards Lifesciences made up 0.04% of Paradigm Asset Management's portfolio in Q3 2026, its #252 holding.
  • Paradigm Asset Management first reported a position in Edwards Lifesciences in Q2 2022 and has held it in 4 quarters since.
  • Paradigm Asset Management's Edwards Lifesciences position peaked at $342K in Q2 2022.
  • 966 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Paradigm Asset Management's 13F filing for Q3 2026, filed 5 Nov 2026.